This conference will provide attendees with one of the few opportunities to focus exclusively on diagnostics and discuss today's latest developments by industry experts. A wide variety of important topics will be covered, including novel diagnostic technologies, new diagnostic biomarkers, clinical utility, next generation sequencing, regulatory landscape for diagnostics, and health economics value of biomarkers and reimbursement environment.